Phase II Double Blind Randomized Trial Evaluating the Biologic Effect of Levonorgestrel on the Ovarian Epithelium in Women at High Risk for Ovarian Cancer (IND 79,610).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Nov 2019 Biomarkers information updated
- 28 Jan 2013 Planned End Date changed from 1 Mar 2010 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 28 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.